目錄:杭州斯達特生物科技有限公司>>抗體/抗原>>Biosimilar抗體>> S0B0556Anti-PD-L1 Monoclonal Antibody(Avelumab)
Avelumab is a fully human monoclonal antibody medication for the treatment of Merkel cell carcinoma, urothelial carcinoma, and renal cell carcinoma. Avelumab targets the protein programmed death-ligand 1 (PD-L1).